938 reports of this reaction
13.4% of all ATAZANAVIR SULFATE reports
#1 most reported adverse reaction
DRUG INTERACTION is the #1 most commonly reported adverse reaction for ATAZANAVIR SULFATE, manufactured by Aurobindo Pharma Limited. There are 938 FDA adverse event reports linking ATAZANAVIR SULFATE to DRUG INTERACTION. This represents approximately 13.4% of all 6,992 adverse event reports for this drug.
Patients taking ATAZANAVIR SULFATE who experience drug interaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INTERACTION is a frequently reported adverse event for ATAZANAVIR SULFATE, accounting for a significant proportion of all reports.
In addition to drug interaction, the following adverse reactions have been reported for ATAZANAVIR SULFATE:
The following drugs have also been linked to drug interaction in FDA adverse event reports:
DRUG INTERACTION has been reported as an adverse event in 938 FDA reports for ATAZANAVIR SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INTERACTION accounts for approximately 13.4% of all adverse event reports for ATAZANAVIR SULFATE, making it one of the most commonly reported side effect.
If you experience drug interaction while taking ATAZANAVIR SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.